DK0911037T3 - Ved stuetemperatur lagringsholdbart immunoglobulinpræparat til intravenøs injektion - Google Patents
Ved stuetemperatur lagringsholdbart immunoglobulinpræparat til intravenøs injektionInfo
- Publication number
- DK0911037T3 DK0911037T3 DK98119782T DK98119782T DK0911037T3 DK 0911037 T3 DK0911037 T3 DK 0911037T3 DK 98119782 T DK98119782 T DK 98119782T DK 98119782 T DK98119782 T DK 98119782T DK 0911037 T3 DK0911037 T3 DK 0911037T3
- Authority
- DK
- Denmark
- Prior art keywords
- intravenous injection
- shelf
- life
- room temperature
- immunoglobulin preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Water Supply & Treatment (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29137497 | 1997-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0911037T3 true DK0911037T3 (da) | 2002-12-02 |
Family
ID=17768099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98119782T DK0911037T3 (da) | 1997-10-23 | 1998-10-23 | Ved stuetemperatur lagringsholdbart immunoglobulinpræparat til intravenøs injektion |
Country Status (11)
Country | Link |
---|---|
US (2) | US6159471A (de) |
EP (1) | EP0911037B2 (de) |
KR (1) | KR100632312B1 (de) |
CN (2) | CN1149100C (de) |
AT (1) | ATE224203T1 (de) |
CA (1) | CA2251342A1 (de) |
DE (1) | DE69808012T3 (de) |
DK (1) | DK0911037T3 (de) |
ES (1) | ES2182202T5 (de) |
HK (1) | HK1021698A1 (de) |
PT (1) | PT911037E (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2272870T3 (da) | 1998-06-09 | 2013-08-05 | Csl Behring Ag | Fremgangsmåde til fremstilling af immunoglobuliner med henblik på intravenøs indgivelse og andre immunoglobulin-lignende produkter. |
ES2184594B1 (es) * | 2001-01-17 | 2004-01-01 | Probitas Pharma Sa | Procedimiento para la produccion de gammaglobulina g humana inactivada de virus. |
JP5052736B2 (ja) * | 2001-05-30 | 2012-10-17 | 中外製薬株式会社 | タンパク質製剤 |
TW200300173A (en) * | 2001-11-13 | 2003-05-16 | Nisshin Oillio Ltd | Process for producing concentrated/purified protein using clay mineral composition |
EP2311489A3 (de) | 2002-02-14 | 2013-08-21 | Chugai Seiyaku Kabushiki Kaisha | Formularierung Antikörper-enthaltender Lösungen die einen Zucker als Stabilisator beinhalten. |
US20040033228A1 (en) * | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
MY150740A (en) * | 2002-10-24 | 2014-02-28 | Abbvie Biotechnology Ltd | Low dose methods for treating disorders in which tnf? activity is detrimental |
FR2854801B1 (fr) * | 2003-05-12 | 2006-09-01 | Khorionyx | Implant injectable de globine insoluble |
EP1532983A1 (de) | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Immunoglobulinpräparationen mit erhöhter Stabilität |
US7723306B2 (en) | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
US7611709B2 (en) | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
DE102004022927A1 (de) * | 2004-05-10 | 2005-12-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten |
US7727962B2 (en) | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
EP2033615B1 (de) * | 2006-06-28 | 2017-05-10 | Fujimori Kogyo Co., Ltd. | Flüssigkeitsbehälter |
WO2008100578A2 (en) * | 2007-02-14 | 2008-08-21 | Amgen Inc. | Method of isolating antibodies by precipitation |
EP2527364A1 (de) | 2007-03-29 | 2012-11-28 | Abbott Laboratories | Kristalline Antikörper gegen menschliches IL-12 |
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
KR101912169B1 (ko) | 2010-02-04 | 2018-10-26 | 체에스엘 베링 아게 | 면역글로불린 제제 |
EP2361636A1 (de) | 2010-02-26 | 2011-08-31 | CSL Behring AG | Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat |
US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
TWI606840B (zh) | 2010-11-11 | 2017-12-01 | 艾伯維生物技術有限責任公司 | 具有增進高濃度之抗-TNFα抗體之液體調配物 |
JP5711369B2 (ja) | 2011-06-24 | 2015-04-30 | 旭化成メディカル株式会社 | 蛋白製剤の製造方法 |
TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之i-iv-1部分沉澱 |
CN103341187B (zh) * | 2012-06-28 | 2016-06-22 | 四川远大蜀阳药业股份有限公司 | 一种终端灭活病原微生物的方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4378346A (en) * | 1979-08-15 | 1983-03-29 | Tankersley Donald L | Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production |
FR2582515B1 (fr) * | 1985-05-30 | 1988-11-04 | Merieux Inst | Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues |
JPH0662436B2 (ja) * | 1986-05-19 | 1994-08-17 | 株式会社ミドリ十字 | 静注用免疫グロブリン製剤の製造方法 |
DE3641115A1 (de) * | 1986-12-02 | 1988-06-16 | Lentia Gmbh | Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins |
JP2547556B2 (ja) † | 1987-02-06 | 1996-10-23 | 株式会社 ミドリ十字 | r−グロブリンの液状製剤 |
JP2613409B2 (ja) * | 1987-11-20 | 1997-05-28 | 株式会社ミドリ十字 | 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法 |
US5177194A (en) * | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
DE4125625C2 (de) † | 1991-08-02 | 1999-12-02 | Octapharma Ag Glarus | Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen |
JPH0761935A (ja) * | 1993-08-25 | 1995-03-07 | Green Cross Corp:The | 静注用免疫グロブリン製剤の製造方法 |
JP4003235B2 (ja) * | 1994-09-30 | 2007-11-07 | 三菱ウェルファーマ株式会社 | 静注用免疫グロブリン製剤の製造方法 |
DK0764658T3 (da) * | 1995-09-22 | 2002-04-22 | Zlb Bioplasma Ag | Fremgangsmåde til fremstilling af immunoglobuliner ud fra fraktioner, som opstår ved fraktionering af blodplasma fra mennesker |
CA2232420A1 (en) * | 1997-03-19 | 1998-09-19 | The Green Cross Corporation | Immunoglobulin preparation and preparation process thereof |
-
1998
- 1998-10-23 CN CNB981224407A patent/CN1149100C/zh not_active Expired - Lifetime
- 1998-10-23 ES ES98119782T patent/ES2182202T5/es not_active Expired - Lifetime
- 1998-10-23 EP EP98119782A patent/EP0911037B2/de not_active Expired - Lifetime
- 1998-10-23 AT AT98119782T patent/ATE224203T1/de active
- 1998-10-23 CA CA002251342A patent/CA2251342A1/en not_active Abandoned
- 1998-10-23 KR KR1019980044470A patent/KR100632312B1/ko not_active IP Right Cessation
- 1998-10-23 DK DK98119782T patent/DK0911037T3/da active
- 1998-10-23 PT PT98119782T patent/PT911037E/pt unknown
- 1998-10-23 DE DE69808012T patent/DE69808012T3/de not_active Expired - Lifetime
- 1998-10-23 US US09/177,373 patent/US6159471A/en not_active Expired - Lifetime
- 1998-10-23 CN CNA2004100055299A patent/CN1520885A/zh active Pending
-
2000
- 2000-01-31 HK HK00100597A patent/HK1021698A1/xx not_active IP Right Cessation
- 2000-05-03 US US09/564,641 patent/US6485725B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1520885A (zh) | 2004-08-18 |
DE69808012D1 (de) | 2002-10-24 |
PT911037E (pt) | 2002-12-31 |
DE69808012T2 (de) | 2003-08-14 |
CN1224620A (zh) | 1999-08-04 |
EP0911037B2 (de) | 2007-06-13 |
US6159471A (en) | 2000-12-12 |
CN1149100C (zh) | 2004-05-12 |
CA2251342A1 (en) | 1999-04-23 |
ATE224203T1 (de) | 2002-10-15 |
EP0911037B1 (de) | 2002-09-18 |
DE69808012T3 (de) | 2008-01-24 |
ES2182202T5 (es) | 2007-12-01 |
ES2182202T3 (es) | 2003-03-01 |
US6485725B1 (en) | 2002-11-26 |
EP0911037A1 (de) | 1999-04-28 |
KR100632312B1 (ko) | 2007-05-14 |
KR19990037317A (ko) | 1999-05-25 |
HK1021698A1 (en) | 2000-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0911037T3 (da) | Ved stuetemperatur lagringsholdbart immunoglobulinpræparat til intravenøs injektion | |
DE69834741D1 (de) | Cellulase aus actinomycetes und herstellungsverfahren dafür | |
DE69829308D1 (de) | Cellulase aus actinomycetes und herstellungsverfahren dafür | |
EP1408108A3 (de) | Cellulase aus Actinomycetes und Herstellungverfahren | |
FR2690920B1 (fr) | Dérivés 1-hydrocarbyloxy-2,2,6,6-tétraméthylpipéridiniques de 1,3,5-triazines non-migrants comme stabilisants de matières polymères. | |
DE69631595D1 (de) | Harzzusammensetzung, damit hergestellte form und verfahren zu deren herstellung | |
IS4121A (is) | Hliðstæð aðferð til framleiðslu á 2,6-Díamínópúrín afleiðum | |
DK0530447T3 (da) | Fremgangsmåde til rensning af IgG-monoklonale antistoffer | |
DE69801154D1 (de) | Verfahren zur herstellung von caprolactam in abwesenheit von katalysatoren durch kontakt von 6-aminocapronsäurederivaten mit überhitztem dampf | |
DK1171468T3 (da) | Fremgangsmåde til stabilisering af kimære immunoglobuliner eller immunoglobulinfragmenter, samt stabiliseret anti-EGP-2-scFv-fragment | |
DE3788273D1 (de) | Verfahren zur Herstellung von Harzen, welche bei Raumtemperatur härten. | |
DK0626452T3 (da) | Vaccine mod infektion af Streptococcus suis | |
ATE7184T1 (de) | Waermeschrumpfbarer artikel und verfahren zu dessen herstellung. | |
DK302190D0 (da) | Fremgangsmaade til behandling af neurologiske tilstande | |
TR28858A (tr) | Insektisid özellikte N'-sübstitüe edilmis-N, N'-diacilhidrazinleri üretmeye mahsus yöntem. | |
ATA171686A (de) | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen | |
DK1105508T3 (da) | Fremgangsmåde til oprensning af biomolekyle- eller proteinkomplekser | |
DK0556683T3 (da) | Fremgangsmåde til fremstilling af 2-chlor-5-methyl-pyridin | |
WO1999054349A3 (en) | Dermatophagoides nucleic acid molecules, proteins and uses thereof | |
ES8304431A1 (es) | "un metodo para preparar una inmunoglobulina adecuada para administracion intravenosa". | |
DK0676965T3 (da) | Fremgangsmåde til at reducere immunogeniciteten af variable regioner på antistoffer | |
DE3675855D1 (de) | Verfahren zur herstellung von hochmolekularen, gegebenenfalls verzweigten polyarylensulfiden. | |
WO1994025527A3 (en) | Improved bonding resin and methods relating thereto | |
DE69115296D1 (de) | Verfahren zur eigenschaftsverbesserung von beschichteten, verstaerkten thermoplastartikeln und damit hergestellte produkte. | |
ATE201197T1 (de) | Diarinopropanole abgeleitet von aminosäuren |